These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25637365)

  • 21. [Graves' orbitopathy].
    Eckstein A; Esser J
    Klin Monbl Augenheilkd; 2011 May; 228(5):432-8. PubMed ID: 21534176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Radiotherapy of Graves' ophthalmopathy--state of the art and review of the literature].
    Eich HT; Micke O; Seegenschmiedt MH
    Rontgenpraxis; 2007; 56(4):137-44. PubMed ID: 17390953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating Graves' orbitopathy.
    Dolman PJ
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):229-48. PubMed ID: 22632361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thyroid associated orbitopathy: from diagnosis to treatment].
    Hamédani M; Obéric A
    Rev Med Suisse; 2013 Jan; 9(368):66-71. PubMed ID: 23367708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel treatment modalities for Graves' orbitopathy.
    Bartalena L; Lai A; Sassi L; Lombardi V; Dalle Mule I; Gandolfo M; Liparulo L; Azzolini C; Piantanida E; Tanda ML
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():210-6. PubMed ID: 20467365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controversies in thyroid-related orbitopathy: radiation and decompression.
    Hatton MP; Rubin PA
    Int Ophthalmol Clin; 2005; 45(4):1-14. PubMed ID: 16199963
    [No Abstract]   [Full Text] [Related]  

  • 27. Changes in graves' ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves' disease from 2 prospective, randomized, open-label, blinded end point studies.
    Chen DY; Schneider PF; Zhang XS; Luo XY; He ZM; Chen TH
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):1-6. PubMed ID: 24203649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease.
    Lazarus JH
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):273-9. PubMed ID: 22632364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of previous orbital irradiation on the outcome of rehabilitative decompression surgery in graves orbitopathy.
    Baldeschi L; MacAndie K; Koetsier E; Blank LE; Wiersinga WM
    Am J Ophthalmol; 2008 Mar; 145(3):534-540. PubMed ID: 18191092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graves orbitopathy: update on diagnosis and therapy.
    Melcescu E; Horton WB; Kim D; Vijayakumar V; Corbett JJ; Crowder KW; Pitman KT; Uwaifo GI; Koch CA
    South Med J; 2014 Jan; 107(1):34-43. PubMed ID: 24389785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of patient with Gaves' orbitopathy].
    Di Fiore A; Paone L; Rendina R; D'Armiento E; Coccaro C; Alessandrini S; Marenco M; Ulisse S
    Clin Ter; 2012 Nov; 163(6):e463-74. PubMed ID: 23306763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactivation of Graves' orbitopathy after rehabilitative orbital decompression.
    Baldeschi L; Lupetti A; Vu P; Wakelkamp IM; Prummel MF; Wiersinga WM
    Ophthalmology; 2007 Jul; 114(7):1395-402. PubMed ID: 17320178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of Graves' orbitopathy.
    Putta-Manohar S; Perros P
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():182-5. PubMed ID: 20467360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease.
    Zoumalan CI; Cockerham KP; Turbin RE; Volpe NJ; Kazim M; Douglas RS; Feldon SE
    J Neuroophthalmol; 2007 Sep; 27(3):205-14. PubMed ID: 17895822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Graves' ophthalmopathy.
    Wiersinga WM
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survey of common practices among oculofacial surgeons in the Asia-Pacific region: Graves' orbitopathy.
    Sundar G; Chiam N; Lun K; Koh V
    Orbit; 2014 Oct; 33(5):319-25. PubMed ID: 25121573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orbital radiation therapy for Graves' ophthalmopathy: measuring clinical efficacy and impact.
    Hahn E; Laperriere N; Millar BA; Oestreicher J; McGowan H; Krema H; Gill H; DeAngelis D; Hurwitz J; Tucker N; Simpson R; Chung C
    Pract Radiat Oncol; 2014; 4(4):233-9. PubMed ID: 25012831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management plan and delivery of care in Graves' ophthalmopathy patients.
    Yang M; Perros P
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):303-11. PubMed ID: 22632367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical update: treatment of hyperthyroidism in Graves' ophthalmopathy.
    Azzam I; Tordjman K
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():193-7. PubMed ID: 20467362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment modalities of thyroid related orbitopathy.
    Ahn ES; Subramanian PS
    Indian J Ophthalmol; 2014 Oct; 62(10):999-1002. PubMed ID: 25449934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.